Z
Zealand Pharma
Biotech & Life Sciences · Søborg, Denmark · Founded 1998 · IPO 2017 Unicorn
Ownership
Who owns Zealand Pharma
Estimated cap table from Dealroom's shareholder data — share of equity by holder. Stakes as last recorded by Dealroom (2026). Percentages are indicative.
Some investors are hidden on this public profile. “Other / undisclosed” is the 72.5% not attributed to a named shareholder. See the full cap table on Dealroom →
Zealand Pharma mafia
Startups founded by Zealand Pharma alumni
Former Zealand Pharma employees who went on to start their own companies. Sorted by Dealroom signal score.
Christian GroendahlDenmark
Andrew ParkerUnited States
Elaine SullivanIreland
Florian ReinaudFrance
Ulrik MouritzenDenmark
Peter Holme JensenDenmarkGlobal footprint
Where Zealand Pharma has talent and traffic
team presence
across markets
Talent graph
The shape of Zealand Pharma's talent
Dealroom maps Zealand Pharma's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.
Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.
Patent intelligence
$254M patent portfolio · 119 active families
Where Zealand Pharma concentrates vs peers
Each axis is a top-10 topic across Zealand Pharma and its closest peers. #1 = 100, #10 = 10, absent = 0.
Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.
Capital deployed
Zealand Pharma's 3 investments and acquisitions.
Every disclosed deal where Zealand Pharma appeared as a backer or acquirer, 2019–2022. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
3 deals across Zealand Pharma's capital deployment.
Where the deals concentrate by sector, stage, and decade.
01 · Deployment strategy vs peers
Where Zealand Pharma deploys vs peers
Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.
02 · Portfolio market map
Zealand Pharma's portfolio, mapped.
Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.
Market sentiment
What the market is saying about Zealand Pharma
An AI-synthesized read of the highest-engagement posts about Zealand Pharma on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Zealand Pharma on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.